217 related articles for article (PubMed ID: 25132134)
1. Calcium affects OX1 orexin (hypocretin) receptor responses by modifying both orexin binding and the signal transduction machinery.
Putula J; Pihlajamaa T; Kukkonen JP
Br J Pharmacol; 2014 Dec; 171(24):5816-28. PubMed ID: 25132134
[TBL] [Abstract][Full Text] [Related]
2. Regulation of OX1 orexin/hypocretin receptor-coupling to phospholipase C by Ca2+ influx.
Johansson L; Ekholm ME; Kukkonen JP
Br J Pharmacol; 2007 Jan; 150(1):97-104. PubMed ID: 17115071
[TBL] [Abstract][Full Text] [Related]
3. OX2 orexin/hypocretin receptor signal transduction in recombinant Chinese hamster ovary cells.
Kukkonen JP
Cell Signal; 2016 Feb; 28(2):51-60. PubMed ID: 26582739
[TBL] [Abstract][Full Text] [Related]
4. OX1 orexin receptors activate extracellular signal-regulated kinase in Chinese hamster ovary cells via multiple mechanisms: the role of Ca2+ influx in OX1 receptor signaling.
Ammoun S; Johansson L; Ekholm ME; Holmqvist T; Danis AS; Korhonen L; Sergeeva OA; Haas HL; Akerman KE; Kukkonen JP
Mol Endocrinol; 2006 Jan; 20(1):80-99. PubMed ID: 16141359
[TBL] [Abstract][Full Text] [Related]
5. Arachidonic acid release mediated by OX1 orexin receptors.
Turunen PM; Ekholm ME; Somerharju P; Kukkonen JP
Br J Pharmacol; 2010 Jan; 159(1):212-21. PubMed ID: 20002100
[TBL] [Abstract][Full Text] [Related]
6. The orexin OX1 receptor activates a novel Ca2+ influx pathway necessary for coupling to phospholipase C.
Lund PE; Shariatmadari R; Uustare A; Detheux M; Parmentier M; Kukkonen JP; Akerman KE
J Biol Chem; 2000 Oct; 275(40):30806-12. PubMed ID: 10880509
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin.
Kane JK; Tanaka H; Parker SL; Yanagisawa M; Li MD
Biochem Biophys Res Commun; 2000 Jun; 272(3):959-65. PubMed ID: 10860858
[TBL] [Abstract][Full Text] [Related]
8. Orexin-A activates hypothalamic AMP-activated protein kinase signaling through a Ca²⁺-dependent mechanism involving voltage-gated L-type calcium channel.
Wu WN; Wu PF; Zhou J; Guan XL; Zhang Z; Yang YJ; Long LH; Xie N; Chen JG; Wang F
Mol Pharmacol; 2013 Dec; 84(6):876-87. PubMed ID: 24068427
[TBL] [Abstract][Full Text] [Related]
9. Orexin/hypocretin activates mTOR complex 1 (mTORC1) via an Erk/Akt-independent and calcium-stimulated lysosome v-ATPase pathway.
Wang Z; Liu S; Kakizaki M; Hirose Y; Ishikawa Y; Funato H; Yanagisawa M; Yu Y; Liu Q
J Biol Chem; 2014 Nov; 289(46):31950-31959. PubMed ID: 25278019
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the orexin/hypocretin receptor agonist Nag 26.
Rinne MK; Leino TO; Turku A; Turunen PM; Steynen Y; Xhaard H; Wallén EAA; Kukkonen JP
Eur J Pharmacol; 2018 Oct; 837():137-144. PubMed ID: 30194937
[TBL] [Abstract][Full Text] [Related]
11. Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR.
Smart D; Jerman JC; Brough SJ; Rushton SL; Murdock PR; Jewitt F; Elshourbagy NA; Ellis CE; Middlemiss DN; Brown F
Br J Pharmacol; 1999 Sep; 128(1):1-3. PubMed ID: 10498827
[TBL] [Abstract][Full Text] [Related]
12. OX1 orexin/hypocretin receptor activation of phospholipase D.
Jäntti MH; Putula J; Somerharju P; Frohman MA; Kukkonen JP
Br J Pharmacol; 2012 Feb; 165(4b):1109-23. PubMed ID: 21718304
[TBL] [Abstract][Full Text] [Related]
13. Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades.
Spinazzi R; Ziolkowska A; Neri G; Nowak M; Rebuffat P; Nussdorfer GG; Andreis PG; Malendowicz LK
Int J Mol Med; 2005 May; 15(5):847-52. PubMed ID: 15806308
[TBL] [Abstract][Full Text] [Related]
14. G-protein-dependency of orexin/hypocretin receptor signalling in recombinant Chinese hamster ovary cells.
Kukkonen JP
Biochem Biophys Res Commun; 2016 Aug; 476(4):379-385. PubMed ID: 27237973
[TBL] [Abstract][Full Text] [Related]
15. Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis.
Nicole P; Couvineau P; Jamin N; Voisin T; Couvineau A
Br J Pharmacol; 2015 Nov; 172(21):5211-23. PubMed ID: 26282891
[TBL] [Abstract][Full Text] [Related]
16. Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity.
Turku A; Rinne MK; Boije Af Gennäs G; Xhaard H; Lindholm D; Kukkonen JP
PLoS One; 2017; 12(6):e0178526. PubMed ID: 28575023
[TBL] [Abstract][Full Text] [Related]
17. Lipid signaling cascades of orexin/hypocretin receptors.
Kukkonen JP
Biochimie; 2014 Jan; 96():158-65. PubMed ID: 23810911
[TBL] [Abstract][Full Text] [Related]
18. Orexin receptors couple to Ca2+ channels different from store-operated Ca2+ channels.
Kukkonen JP; Akerman KE
Neuroreport; 2001 Jul; 12(9):2017-20. PubMed ID: 11435939
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor.
Tsujino N; Yamanaka A; Ichiki K; Muraki Y; Kilduff TS; Yagami K; Takahashi S; Goto K; Sakurai T
J Neurosci; 2005 Aug; 25(32):7459-69. PubMed ID: 16093397
[TBL] [Abstract][Full Text] [Related]
20. OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms.
Holmqvist T; Johansson L; Ostman M; Ammoun S; Akerman KE; Kukkonen JP
J Biol Chem; 2005 Feb; 280(8):6570-9. PubMed ID: 15611118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
